Content
University of Oxford
This trial will be coordinated by OCTO (Oncology Clinical Trials Office) which is part of the UKCRC registered Oxford Clinical Trials Research Unit (OCTRU) at the University of Oxford.
Footer Columns
Title
Sponsor
Include this footer block
On
Include this footer block
On
Content
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (an MRC and NIHR partnership) and Cancer Research UK.
Title
Funder
Include this footer block
On
Content
Footer 4 content
Title
Footer 4
Include this footer block
Off
